HSTC — HST Global, Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 797564 ·
Last close
$0.70
Market Cap
$99.00M
52W High
$1.05
52W Low
$0.00
ADV30
98
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2024 | 0 | — | -13,400 | -13,792 | 1,281,070 | 10,406 | 42,076 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-18,549
Investing CF
—
Financing CF
$23,800
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.00
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-6,079,160
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-13,400
Pretax Income TTM
$-13,792
Interest Exp TTM
$392
Analysts
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2023 | 0 | -140,907 | -146,210 | 1,526 | 593,593 | -592,067 | -20,906 |
| Dec 2022 | 0 | -141,035 | -145,074 | 190 | 446,047 | -445,857 | -21,035 |
| Dec 2021 | 0 | -145,718 | -148,360 | 225 | 301,008 | -300,783 | -29,836 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-101,508
OpCashFlow TTM
—
Assets (Latest)
$1,281,070
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BMEA | Biomea Fusion, Inc. | $99.05M | $1.37 | — |
| PLYX | Polaryx Therapeutics, Inc. | $99.69M | $2.00 | — |
| KZIA | KAZIA THERAPEUTICS LTD | $100.79M | $8.82 | — |
| ANIX | Anixa Biosciences Inc | $101.16M | $2.91 | — |
| SMNR | Semnur Pharmaceuticals, Inc. | $96.69M | $0.42 | — |
Recent Insider Activity
No insider activity indexed for this ticker.